enVVeno Medical (NASDAQ:NVNO) Trading Down 1.8%

enVVeno Medical Corporation (NASDAQ:NVNO) shares dropped 1.8% during mid-day trading on Wednesday . The stock traded as low as $5.56 and last traded at $5.95. Approximately 39,992 shares were traded during mid-day trading, a decline of 62% from the average daily volume of 106,186 shares. The stock had previously closed at $6.06.

enVVeno Medical Price Performance

The company has a 50 day simple moving average of $5.07 and a 200-day simple moving average of $5.09. The firm has a market cap of $79.31 million, a PE ratio of -3.58 and a beta of 1.24.

enVVeno Medical (NASDAQ:NVNO) last announced its quarterly earnings data on Wednesday, May 8th. The company reported ($0.31) earnings per share for the quarter. On average, sell-side analysts predict that enVVeno Medical Corporation will post -1.4 EPS for the current fiscal year.

Institutional Trading of enVVeno Medical

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Acadian Asset Management LLC bought a new position in shares of enVVeno Medical during the first quarter valued at approximately $37,000. Fermata Advisors LLC raised its holdings in shares of enVVeno Medical by 37.8% during the fourth quarter. Fermata Advisors LLC now owns 16,325 shares of the company’s stock valued at $84,000 after acquiring an additional 4,475 shares in the last quarter. Quadrature Capital Ltd bought a new position in shares of enVVeno Medical during the first quarter valued at approximately $103,000. Janney Montgomery Scott LLC bought a new position in shares of enVVeno Medical during the first quarter valued at approximately $186,000. Finally, Westside Investment Management Inc. raised its holdings in shares of enVVeno Medical by 933.7% during the second quarter. Westside Investment Management Inc. now owns 38,762 shares of the company’s stock valued at $204,000 after acquiring an additional 35,012 shares in the last quarter. Institutional investors own 34.71% of the company’s stock.

About enVVeno Medical

enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company’s lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).